Similar to Oxford-Astrazeneca’s COVID-19 vaccine (Covishield in India), which has been associated with severe side effects, experts have also linked Janssen’s COVID vaccine to unusual blood clot risks with low levels of blood platelets.
According to the official website of Johnson & Johnson’s website, “Blood clots involving blood vessels in the brain, lungs, abdomen, and legs along with low levels of platelets (blood cells that help your body stop bleeding), have occurred in some people who have received the Janssen COVID-19 Vaccine.”
Those of whom who developed the symptoms did so in about one to two-weeks following vaccination. Such cases have been seen mostly in females ages 18 through 49 years. However, it has been said that the occurrence of such cases is very low.
Symptoms may include chest pain, shortness of breath, leg swelling, severe head aches and continuous abdominal pain.